BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1551371)

  • 21. [Cytology of reversible and irreversible epithelial changes in the uterine cervix].
    Höffken H
    Fortschr Med; 1977 Oct; 95(39):2382-6. PubMed ID: 914197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrospective DNA analyses in cervical dysplasia as related to neoplastic progression or regression.
    Nasiell K; Auer G; Nasiell M; Zetterberg A
    Anal Quant Cytol; 1979; 1(2):103-6. PubMed ID: 543572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Accompanying histological changes in the cervix uteri in carcinoma in situ and early invasive carcinoma].
    Krizanac S; Jukić S; Bolanca M
    Lijec Vjesn; 1987; 109(11-12):418-21. PubMed ID: 3695790
    [No Abstract]   [Full Text] [Related]  

  • 24. [Dysplasia and carcinoma in situ of the uterine cervix in pregnancy].
    Pajtler M; Cugalj B; Milojković M; Makarović Z
    Jugosl Ginekol Perinatol; 1990; 30(1-2):15-8. PubMed ID: 2214848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Histogenesis and pathological anatomy of dysplasias of the uterine cervix].
    Toledo J; Bau S; Marcuello AC; Jurado M; Laparte C; López García G; de la Fuente F
    Rev Med Univ Navarra; 1980 Dec; 24(4):20-5. PubMed ID: 7336008
    [No Abstract]   [Full Text] [Related]  

  • 26. False-negative Papanicolaou smears from women with cancerous and precancerous lesions of the uterine cervix.
    Pairwuti S
    Acta Cytol; 1991; 35(1):40-6. PubMed ID: 1994633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytomorphologic and cytochemical analysis in the differential diagnosis of cervical epithelial lesions.
    Nasiell K; Näslund I; Auer G
    Anal Quant Cytol; 1984 Sep; 6(3):196-200. PubMed ID: 6508037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative assessment of oxyphilic cell lesions of the thyroid gland on fine needle aspiration samples.
    Zeppa P; Benincasa G; Troncone G; Zabatta A; Fulciniti F; Vetrani A; Palmieri EA; Palombini L
    Anal Quant Cytol Histol; 2001 Jun; 23(3):178-84. PubMed ID: 11444186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear DNA content and the number of Barr bodies in premalignant and malignant lesions of the uterine cervix.
    Nishiya I; Ishizaki Y; Sasaki M
    Acta Cytol; 1981; 25(4):407-11. PubMed ID: 6945007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysplasia, carcinoma in situ, and microinvasive carcinoma of the uterine cervix.
    Christopherson WM
    Hum Pathol; 1977 Sep; 8(5):489-501. PubMed ID: 903142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conization for cervical dysplasia and carcinoma in situ: long term follow-up of 1013 women.
    Larsson G
    Ann Chir Gynaecol; 1981; 70(2):79-85. PubMed ID: 7316444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Histo-cytologic study on the development of moderate cervical dysplasia (cervical intraepithelial neoplasm 2) followed in 267 cases].
    Eleuteri Serpieri D; Buzzi M; Palazzetti PL; Alessandrini A
    Minerva Ginecol; 1986 Mar; 38(3):139-42. PubMed ID: 3703365
    [No Abstract]   [Full Text] [Related]  

  • 33. [DNA content and prognosis in atypical cervix epithelium].
    Bergleiter R
    Zentralbl Gynakol; 1986; 108(19):1164-9. PubMed ID: 3811665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Foundations for differential cytology of cervical changes. 3. Dysplasia and carcinoma in situ (author's transl)].
    Höffken H; Rummel HH
    Zentralbl Gynakol; 1981; 103(24):1517-36. PubMed ID: 7340303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological behaviour of moderate dysplasia--a prospective study.
    Murthy NS; Sardana S; Narang N; Agarwal SS; Sharma S; Das DK
    Indian J Cancer; 1996 Mar; 33(1):24-30. PubMed ID: 9063015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ultrastructural characteristics of cervical dysplasia and carcinoma in situ].
    Iakovleva IA; Chernyĭ AP
    Arkh Patol; 1982; 44(6):20-6. PubMed ID: 7125928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular biologic study on the carcinogenesis of HPV in uterine cervical cancer and related lesions--analysis of HPV types 16, 18 E6/E7 gene mRNA].
    Nagai N
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):823-33. PubMed ID: 2172419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA-cytometric diagnosis of prospective malignancy in borderline lesions of the uterine cervix.
    Böcking A; Hilgarth M; Auffermann W; Hack-Werdier C; Fischer-Becker D; von Kalkreuth G
    Acta Cytol; 1986; 30(6):608-15. PubMed ID: 3466496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two types of cells in the normal and atypical squamous epithelium of the cervix. II. Light microscopic study in human subjects.
    Rubio CA
    Acta Cytol; 1982; 26(2):121-5. PubMed ID: 6952710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The invasive potential of carcinoma in situ of the cervix.
    McIndoe WA; McLean MR; Jones RW; Mullins PR
    Obstet Gynecol; 1984 Oct; 64(4):451-8. PubMed ID: 6483293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.